Arcus Capital Partners’s Organon & Co OGN Stock Holding History

Arcus Capital Partners’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-160	Closed	-$4.47K	–	271
2022 Q4	$4.47K	Buy	+160	New	+$4.09K	﹤0.01%	301

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arcus Capital Partners's OGN Position: Q1 2023 in Review

Arcus Capital Partners sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 160 shares — an estimated $4.47K sold.

Arcus Capital Partners first reported a position in OGN in Q4 2022 and held it in 1 quarter. The position peaked at $4.47K in Q4 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

Arcus Capital Partners reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
Arcus Capital Partners sold 160 Organon & Co shares in Q1 2023, an estimated $4.47K.
Arcus Capital Partners first reported a position in Organon & Co in Q4 2022 and held it in 1 quarter.
Arcus Capital Partners's Organon & Co position peaked at $4.47K in Q4 2022.
767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.